Answers are grounded in this paper and cite their sources.
Objective: To quantify pain-related placebo responses across treatment modalities in placebo-controlled clinical trials of non-surgical osteoarthritis interventions. Design: statistic, and sources of variance were analyzed with multivariate meta-regression. Results: = 88%, p < 0.0001), with a wide prediction interval (-0.31 to 1.60). Multivariate meta-regression identified four covariates that together accounted for 33% of the explained variance: baseline pain, funding source, effect size in the active treatment arm, and geographical region. In subgroup analysis, outcomes were not significantly affected by treatment modality. Trials conducted in North America reported the highest effect sizes. Conclusion: Most trials reported moderate to large effect sizes for improvement in the placebo group. Treatment modality did not significantly affect outcomes and most of the variance in the placebo response remained unexplained. Important limitations include substantial statistical heterogeneity, the lack of data on psychological variables and few trials with a no-treatment group.
No takes yet. Share an insight, caveat, or question.
Holtedahl et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: